Bath & Body Works, Inc. (NYSE:BBWI) Given Consensus Recommendation of “Hold” by Brokerages

Bath & Body Works, Inc. (NYSE:BBWI) has earned a consensus rating of “Hold” from the nineteen research firms that are presently covering the company, MarketBeat reports. One analyst has rated the stock with a sell recommendation, fourteen have assigned a hold recommendation and four have issued a buy recommendation on the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $22.1333.

Several brokerages have recently weighed in on BBWI. TD Cowen lifted their target price on shares of Bath & Body Works from $20.00 to $25.00 and gave the company a “buy” rating in a research report on Thursday, May 28th. JPMorgan Chase & Co. raised their price target on shares of Bath & Body Works from $22.00 to $24.00 and gave the stock a “neutral” rating in a research note on Tuesday, August 18th. BMO Capital Markets started coverage on Bath & Body Works in a report on Tuesday. They set a “market perform” rating and a $20.00 price objective on the stock. Barclays lowered their price objective on Bath & Body Works from $23.00 to $22.00 and set an “equal weight” rating on the stock in a research note on Thursday, August 27th. Finally, Robert W. Baird dropped their target price on Bath & Body Works from $25.00 to $23.00 and set a “neutral” rating for the company in a report on Thursday, August 27th.

Bath & Body Works Trading Up 6.3%

Shares of NYSE BBWI opened at $18.56 on Friday. The firm has a market capitalization of $3.74 billion, a price-to-earnings ratio of 4.83, a PEG ratio of 1.80 and a beta of 1.38. Bath & Body Works has a one year low of $14.27 and a one year high of $27.82. The business has a fifty day simple moving average of $19.64 and a 200 day simple moving average of $19.63.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings results on Wednesday, August 26th. The company reported $0.62 earnings per share for the quarter, topping analysts’ consensus estimates of $0.24 by $0.38. Bath & Body Works had a net margin of 10.83% and a negative return on equity of 53.48%. The firm had revenue of $1.51 billion for the quarter, compared to the consensus estimate of $1.50 billion. During the same quarter in the previous year, the company earned $0.30 earnings per share. The business’s revenue was down 2.3% compared to the same quarter last year. Bath & Body Works has set its Q3 2026 guidance at 0.070-0.120 EPS and its FY 2026 guidance at 2.600-2.800 EPS. On average, research analysts anticipate that Bath & Body Works will post 2.73 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, September 4th. Shareholders of record on Friday, August 21st were given a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 4.3%. The ex-dividend date was Friday, August 21st. Bath & Body Works’s dividend payout ratio is 20.83%.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in BBWI. Global Retirement Partners LLC bought a new stake in shares of Bath & Body Works in the 4th quarter worth about $31,000. Geneos Wealth Management Inc. lifted its holdings in Bath & Body Works by 217.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after purchasing an additional 801 shares during the last quarter. Parallel Advisors LLC lifted its holdings in Bath & Body Works by 42.6% during the 4th quarter. Parallel Advisors LLC now owns 1,897 shares of the company’s stock valued at $38,000 after purchasing an additional 567 shares during the last quarter. Danske Bank A S acquired a new position in Bath & Body Works in the third quarter valued at about $39,000. Finally, Elevation Wealth Partners LLC grew its stake in Bath & Body Works by 5,278.8% during the second quarter. Elevation Wealth Partners LLC now owns 1,775 shares of the company’s stock worth $41,000 after buying an additional 1,742 shares during the last quarter. 95.14% of the stock is owned by institutional investors.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailer focused on personal care and home-fragrance products. Its offerings include body lotions and creams, shower gels, fragrance mists, hand soaps and sanitizers, candles, home fragrances, and related seasonal merchandise. The company markets products under the Bath & Body Works and White Barn names.

The company sells its products through a network of company-operated stores, its websites, and other direct channels. Its retail operations primarily serve customers in the United States and Canada, while international markets are reached through franchised, licensed, and other distribution arrangements.

Bath & Body Works traces its origins to 1990 and was formerly part of L Brands, Inc It became an independent publicly traded company in 2021 following the separation of L Brands’ Victoria’s Secret business.